About Dr. Chen Shengdi
Dr. Chen Shengdi (陈生弟) is Chief Physician, Professor, and Director of the Department of Neurology at Renji Hospital, Shanghai Jiao Tong University School of Medicine. He is China's foremost authority on Parkinson's disease and movement disorders, and one of the most internationally recognized Chinese neurologists in this subspecialty. His clinical program at Renji Hospital manages one of the largest Parkinson's disease cohorts in Asia, and his research has fundamentally shaped the understanding and treatment of Parkinson's disease in Chinese patients.
Dr. Chen has dedicated his career to the full spectrum of Parkinson's disease management — from early diagnosis and neuroprotective strategies through advanced disease management including deep brain stimulation (DBS) — as well as the broader category of movement disorders including essential tremor, dystonia, multiple system atrophy, and progressive supranuclear palsy. His multidisciplinary Parkinson's program at Renji integrates neurology, neurosurgery (DBS), rehabilitation medicine, neuropsychology, and nursing to provide comprehensive, patient-centered care that is genuinely comparable to the world's leading movement disorder centers.
Hospital Affiliation
Renji Hospital of Shanghai Jiao Tong University School of Medicine is one of China's top-ranked general hospitals with particular strength in neurology, neurosurgery, and neurological rehabilitation. The Department of Neurology at Renji operates a dedicated Movement Disorder Clinic and Parkinson's Disease Center, providing specialized assessment and management for patients with Parkinson's disease and related conditions. The department's DBS program — conducted in close collaboration with Renji's neurosurgery team — is one of the most experienced in China, with a large cumulative case volume and established protocols for patient selection, programming, and long-term follow-up.
Clinical Expertise
- Parkinson's disease — early and accurate diagnosis; dopaminergic therapy optimization (levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors); motor fluctuation and dyskinesia management; non-motor symptom management (cognitive impairment, depression, autonomic dysfunction, sleep disorders)
- Deep brain stimulation (DBS) — patient selection and pre-surgical evaluation; STN-DBS and GPi-DBS; programming and long-term optimization; DBS for tremor, dystonia, and OCD
- Essential tremor — pharmacological management; DBS and focused ultrasound thalamotomy evaluation
- Dystonia — focal dystonia (cervical dystonia, blepharospasm, writer's cramp); botulinum toxin injection; generalized dystonia; DBS for refractory dystonia
- Atypical parkinsonian syndromes — multiple system atrophy (MSA); progressive supranuclear palsy (PSP); corticobasal syndrome (CBS); dementia with Lewy bodies (DLB)
- Parkinson's disease dementia & cognitive impairment — neuropsychological assessment; cholinesterase inhibitor therapy; caregiver support
- Botulinum toxin therapy — spasticity; dystonia; hemifacial spasm; sialorrhea
Academic & Research Contributions
Dr. Chen Shengdi is one of China's most prolific and internationally cited neurologists, with an extensive publication record in leading neurology journals including Brain, Annals of Neurology, Movement Disorders, and JAMA Neurology. His research has advanced the understanding of the genetic basis of Parkinson's disease in Chinese populations, the pathophysiology of motor complications, and the optimization of DBS therapy. He has led multiple national-level research programs on Parkinson's disease funded by the National Natural Science Foundation of China and the Ministry of Science and Technology.
He serves in leadership positions in the Chinese Society of Parkinson's Disease and Movement Disorders and the Chinese Society of Neurology, contributing to the development of national clinical practice guidelines for Parkinson's disease management. He is a frequent invited speaker at major international neurology conferences including the International Congress of Parkinson's Disease and Movement Disorders, and maintains active research collaborations with leading movement disorder centers globally.
Why International Patients Choose Dr. Chen Shengdi
Parkinson's disease is a lifelong condition requiring expert subspecialty management that evolves significantly as the disease progresses. Many international patients — particularly those in early or mid-stage disease — seek Dr. Chen's expertise for a comprehensive second opinion on diagnosis and treatment optimization, evaluation for DBS candidacy, or management of complex motor fluctuations and non-motor symptoms that have been difficult to control with standard therapy.
Dr. Chen's program offers a level of Parkinson's disease expertise — combining high-volume clinical experience, cutting-edge research, and a fully integrated multidisciplinary team — that is genuinely comparable to the world's leading movement disorder centers, at a fraction of the cost of equivalent care in Western healthcare systems. For patients of Chinese heritage living abroad, consultation with Dr. Chen also provides culturally and linguistically appropriate care from China's foremost Parkinson's specialist.
What to Expect at Your Consultation
Consultations with Dr. Chen begin with a comprehensive neurological assessment including detailed history, motor and non-motor symptom evaluation, standardized rating scales (MDS-UPDRS), review of prior neuroimaging (MRI, DaTscan if available), and current medication review. CMCS will arrange certified translation of all prior medical records in advance. Dr. Chen will provide a definitive diagnostic assessment, optimize your medication regimen, and — where appropriate — initiate evaluation for DBS candidacy. A written English-language consultation summary is provided after every appointment.
Frequently Asked Questions
How do I know if I am a candidate for deep brain stimulation?
DBS is most effective for patients with Parkinson's disease who have significant motor fluctuations or dyskinesias despite optimized medical therapy, who retain good cognitive function, and who have had a clear and sustained response to levodopa. Dr. Chen's team conducts a structured pre-surgical evaluation including neuropsychological testing, psychiatric assessment, and levodopa challenge testing to determine DBS candidacy.
I have been diagnosed with Parkinson's disease but am not sure the diagnosis is correct — can Dr. Chen provide a second opinion?
Yes. Diagnostic accuracy in early Parkinson's disease and differentiation from atypical parkinsonian syndromes is one of Dr. Chen's core clinical strengths. He will conduct a comprehensive reassessment including clinical examination, review of prior imaging, and — where indicated — DaTscan or additional neuroimaging to confirm or revise the diagnosis.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking Parkinson's disease and movement disorder care with Dr. Chen Shengdi at Renji Hospital, including priority appointment scheduling, certified medical translation, pre-consultation record review, DBS evaluation coordination, and written English consultation summary. Contact us at contact@medicalsh.com, , or visit medicalsh.com.
0 comentarios